Stent FREDX5015-PMARecalls & reported problems
Microvention, Inc. · FRED-X 27 · Class 3 · Implant
All models of Stent (63)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 8
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00842429114445), received between Feb 28, 2023 and Apr 13, 2026 — classified as 6 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Activation Problem” (3 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Recalls naming this device
- Sep 5, 2025Open, Classified
Flow diverter may have a manufacturing issue related to the tantalum length and/or tantalum attachment pattern, which may lead the device to be incompletely open or not properly apposed to the vessel wall, which may necessitate device recapture and withdrawal of the delivery system and microcatheter together. Insufficient apposition could lead to long-term health consequences.
Z-0108-2026 · Root cause: Device Design · Recall details · FDA record ↗
Most reported problems
Device problems
- Activation Problem3
- Migration2
- Adverse Event Without Identified Device or Use Problem1
- Difficult or Delayed Separation1
- Difficult to Fold, Unfold or Collapse1
- Difficult to Open or Close1
- Retraction Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions6
- Thrombosis/Thrombus2
- Cramp(s) /Muscle Spasm(s)1
- Ischemia Stroke1
- Muscle Weakness/Atrophy1
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
InjuryApr 13, 2026Activation Problem
NO NEW INFORMATION PROVIDED. SEE SECTION B3 FOR DATE OF EVENT CORRECTION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24865615 ↗InjuryDec 26, 2025Migration; Migration
IT WAS REPORTED THAT THE FLOW DIVERTER STENT WAS USED TO TREAT A PREVIOUSLY TREATED RUPTURED POSTERIOR COMMUNICATING ARTERY (PCOM) ANEURYSM. THERE WAS A REMNANT FROM THE USE OF AN INTRALUMINAL FLOW DISRUPTION WEB DEVICE IN THIS RUPTURED PCOM. THE ANEURYSM LOCATION WAS AT DISTAL ICA. DISTAL MEASUREMENT OF THE ICA WAS 4.4MM AND PROXIMAL LANDING ZONE TO THE ANEURYSM MEASURED 3.8MM. THE SIZE OF STENT CHOSEN WAS A 5X15/9. PROPER PREP OF THE STENT WAS COMPLETED BEFORE ADVANCING INTO THE MICROCATHETER. THE DEVICE OPENED AND DEPLOYED NICELY WITH GOOD APPOSITION TO THE VESSEL WALL. REPORTEDLY, ABOUT 3 HOURS LATER, THE PHYSICIAN REPORTED THAT THE PATIENT HAD EXPERIENCED STROKE SYMPTOMS AND COULD NOT MOVE HALF OF THEIR BODY. THE PATIENT WAS TAKEN BACK TO THE ANGIO SUITE FOR IMAGING WHERE IT WAS DISCOVERED THAT THE STENT HAD MIGRATED INTO THE M1 SEGMENT AND HAD CLOT FORMATION INSIDE. THE PATIENT WAS GIVEN INTEGRALIN AND HAS IMPROVED. REPORTEDLY, THERE WAS SPASM EARLIER IN THE PROCEDURE. VERAPAMIL WAS GIVEN ABOUT 30-45 MINUTES BEFORE STENT WAS DEPLOYED. CURRENTLY THE PATIENT IS DOING A LITTLE BIT BETTER, BUT STILL HAD A STROKE AND IS WEAK ON THE LEFT SIDE. THE STENT WAS OVERSIZED AND WAS OPPOSE
Patient problems: Cramp(s) /Muscle Spasm(s); Ischemia Stroke; Muscle Weakness/Atrophy; Thrombosis/Thrombus
MAUDE report 23898338 ↗InjuryFeb 8, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED: CASE WAS FLOW DIVERSION OF THE ICA. WE SELECTED THE FREDX SIZE FOR THE VESSEL AND PREPPED PER IFU. UPON ATTEMPT AT DEPLOYMENT STENT BEGAN TO OPEN DISTALLY & THEN STOPPED OPENING. WE RECAPTURED AND REMOVED DEVICE CHECKED AGAIN IN BOWL LOOKED LIKE IT WAS OPEN OK SO WE ATTEMPTED A SECOND ATTEMPT. UPON SECOND ATTEMPT TO DEPLOY DEVICE IT AGAIN OPENED DISTALLY BUT WOULD NOT OPEN IN THE MIDDLE. WE REMOVED DEVICE, SELECTED A DIFFERENT SIZE AND LENGTH OF DEVICE AND PREPPED AN INTRODUCED NEW FRED X. THE NEW DEVICE OPENED AND DEPLOYED JUST AS PLANNED. PATIENT WOKE UP POST PROCEDURE AND APPEARED TO HAVE MOBILITY OF ALL EXTREMATIES. POSSIBLE EFFASIA BUT WAS NOT COMPLETELY AWAKE AND FULLY ASSESSED AT THAT TIME. DESCRIPTION OF INTERVENTION: AFTER DEVICE DEPLOYMENT UPON DOING COMPLETION RUNS WE NOTICED CLOT IN THE M1/M2 SEGMENT. WE CROSSED BACK THROUGH THE FLOW DIVERTER WITH A HEADWAY 21 AND A SOFIA 5F 125 AND WENT AFTER THE CLOT 1ST PASS WITH TREVO STENT TREAVER OPEN UP M1/M2 BUT CLOT MOVED DISTAL WE MADE SECOND PASS WITH TREVO AND WERE ABLE TO RETRIEVE CLOT. PATIENT CURRENT CONDITION/OUTCOME: PATIENT WAS IMPROVING IMMEDIATE POSTOPERATIVE UNTIL ICU TRANSFER. WAS DOING WELL BUT FOLLOW
Patient problems: Thrombosis/Thrombus
MAUDE report 21340668 ↗InjuryJan 7, 2025Difficult to Fold, Unfold or Collapse; Difficult to Fold, Unfold or Collapse
AS REPORTED THROUGH THE FRED X PAS CLINICAL STUDY: INCOMPLETE OPEN OF THE FRED X DEVICE DISTAL TO THE ANEURYSM. THIS TECHNICAL EVENT COULD NOT HAVE LED TO A SERIOUS ADVERSE DEVICE EFFECT (SADE). INCOMPLETE STENT EXPANSION OCCURRED AFTER DEVICE WAS DETACHED AND A BALLOON ANGIOPLASTY WAS PERFORMED. DEVICE WAS IMPLANTED WITH NO VISIBLE ENDOLEAK POST BALLOON ANGIOPLASTY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21098534 ↗MalfunctionMay 14, 2024Activation Problem; Activation Problem
IT WAS REPORTED THAT THE FLOW DIVERTER STENT WAS USED IN THE TREATMENT OF AN INTERNAL CAROTID ARTERY (ICA) ANEURYSM. REPORTEDLY, ON 6-MONTH FOLLOW-UP VISIT, IT WAS NOTED THAT THE STENT WAS POTENTIALLY NOT WELL OPPOSED TO THE VESSEL WALL AT THE PROXIMAL PORTION OF THE STENT. THE PATIENT IS ASYMPTOMATIC AND THE PHYSICIAN IS NOT DOING ANYTHING FURTHER AND IS WATCHING THE PATIENT AT THIS TIME. DATE OF INDEX PROCEDURE WAS NOT PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19316264 ↗MalfunctionDec 22, 2023Retraction Problem; Difficult to Open or Close; Retraction Problem; Difficult to Open or Close
AS REPORTED THROUGH A FRED X CLINICAL STUDY, THE FRED X DEPLOYED AS INTENDED AT THE DISTAL LANDING ZONE, OPENED ACROSS THE NECK, BUT FAILED TO OPEN ALONG THE PROXIMAL CURVATURE. THE FRED X COULD NOT BE CAPTURED, RETRACTED WITHIN THE MICROCATHETER. THE DEVICE WAS SUCCESSFULLY RECAPTURED THROUGH THE ADVANCEMENT OF THE INTERMEDIATE CATHETER. A PIPELINE STENT WAS PLACED SUCCESSFULLY. NO PATIENT HARM WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18387539 ↗InjuryOct 24, 2023Migration; Difficult or Delayed Separation; Migration; Difficult or Delayed Separation
ADDITIONAL INFORMATION PROVIDED INDICATED A PIPELINE STENT WAS PLACED DISTAL TO THE PREVIOUSLY IMPLANTED FRED X ON (B)(6) 2023. THE PATIENT WAS DISCHARGED WITHOUT FURTHER SEQUELA.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18000299 ↗InjuryFeb 28, 2023Activation Problem; Activation Problem
IT WAS REPORTED THAT A FLOW DIVERTER WAS IMPLANTED IN THE PATIENT PARTIALLY OPENED. AN ATTEMPT WAS MADE TO OPEN THE STENT FULLY BY USING A BALLOON, BUT IT FAILED. THE PHYSICIAN DECIDED TO LEAVE THE DEVICE IMPLANTED IN ITS CURRENT POSITION, AND THE PROCEDURE WAS COMPLETED. INTEGRILIN WAS ADMINISTERED. THE PATIENT WAS DISCHARGED AND WENT HOME.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16456146 ↗
Other Intracranial aneurysm flow diverter devices
- Pipeline TM Flex Embolization Device with Shield Technology TM PED2-300-12Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter2 recalls1 report
- PIPELINE PED-500-20Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall31 reports
- PIPELINE PED-500-35Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death29 reports
- PIPELINE PED-500-16Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall2 deaths27 reports
- PIPELINE PED-500-25Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death23 reports
- PIPELINE PED-500-30Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall21 reports
- PIPELINE PED-450-25Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall20 reports
- PIPELINE PED-475-30Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death19 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page